Literature DB >> 22998785

Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.

Gabriel Birgand1, Laurence Armand-Lefevre, Isabelle Lolom, Etienne Ruppe, Antoine Andremont, Jean-Christophe Lucet.   

Abstract

BACKGROUND: The duration of gastrointestinal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) may play a major role in the spread of these organisms. We evaluated the time to, and factors associated with, ESBL-E clearance after hospital discharge.
METHODS: We retrospectively reviewed prospective surveillance results obtained over 14 years in a 1,000-bed hospital. The surveillance collected demographic, hospital stay, microbiologic, and outcome data. An automatic alert system identified readmitted patients with prior ESBL-E carriage. ESBL-E clearance was defined as a negative rectal screening sample at readmission with no new positive clinical sample during the stay. Variables associated with ESBL-E clearance were identified using a Cox model.
RESULTS: We included 1,884 patients with 2,734 admissions. Four hundred forty-eight patients with readmission screening formed the basis for the study. Of 448 patients with 1 to 16 readmissions, 180 (40%) were persistent carriers. The median time to ESBL-E clearance was 6.6 months. Variables independently associated with clearance was having the first positive culture in a screening sample only (adjusted hazard ratio, 1.31; 95% confidence interval, 1.02-1.69; P = .04) and period 2005-2010 (hazard ratio, 1.88; 95% confidence interval, 1.33-2.67; P < .01).
CONCLUSION: We found a long duration of ESBL-E carriage after hospital discharge. An automatic alert system was useful for identifying, screening, and isolating previous ESBL-E carriers.
Copyright © 2013 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22998785     DOI: 10.1016/j.ajic.2012.05.015

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  27 in total

1.  Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.

Authors:  A Mujal; J Sola; M Hernandez; M-A Villarino; M-L Machado; M Baylina; J Tajan; J Oristrell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-06       Impact factor: 3.267

2.  Persistence of colonisation with MDRO following discharge from the ICU.

Authors:  Jean-Christophe Lucet; Despoina Koulenti; Jean-Ralph Zahar
Journal:  Intensive Care Med       Date:  2014-03-08       Impact factor: 17.440

Review 3.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  Long-Term Colonization by bla(CTX-M)-Harboring Escherichia coli in Healthy Japanese People Engaged in Food Handling.

Authors:  Kunihiko Nakane; Kumiko Kawamura; Kensuke Goto; Yoshichika Arakawa
Journal:  Appl Environ Microbiol       Date:  2016-01-08       Impact factor: 4.792

5.  Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.

Authors:  Nenad Macesic; Angela Gomez-Simmonds; Sean B Sullivan; Marla J Giddins; Samantha A Ferguson; Gautam Korakavi; David Leeds; Sarah Park; Kevin Shim; Madeleine G Sowash; Melanie Hofbauer; Ryan Finkel; Yue Hu; Jared West; Nora C Toussaint; William G Greendyke; Benjamin A Miko; Marcus R Pereira; Susan Whittier; Elizabeth C Verna; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

6.  Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients.

Authors:  M Hong Nguyen; Ryan K Shields; Liang Chen; A William Pasculle; Binghua Hao; Shaoji Cheng; Jonathan Sun; Ellen G Kline; Barry N Kreiswirth; Cornelius J Clancy
Journal:  Clin Infect Dis       Date:  2022-02-11       Impact factor: 9.079

7.  ESBL carriage in pig slaughterhouse workers is associated with occupational exposure.

Authors:  W Dohmen; L VAN Gompel; H Schmitt; A Liakopoulos; L Heres; B A Urlings; D Mevius; M J M Bonten; D J J Heederik
Journal:  Epidemiol Infect       Date:  2017-05-02       Impact factor: 4.434

8.  The prevalence of Escherichia coli strains with extended spectrum beta-lactamases isolated in China.

Authors:  Haihong Liu; Yueling Wang; Gang Wang; Quantai Xing; Lihua Shao; Xiaomeng Dong; Lintao Sai; Yongjuan Liu; Lixian Ma
Journal:  Front Microbiol       Date:  2015-04-21       Impact factor: 5.640

9.  A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases.

Authors:  Anna-Karin Jonsson; Anders Larsson; Thomas Tängdén; Åsa Melhus; Anders Lannergård
Journal:  Infect Ecol Epidemiol       Date:  2015-11-09

10.  Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia Coli. an exploratory case-control study.

Authors:  Rasmus Leistner; Elisabeth Meyer; Petra Gastmeier; Yvonne Pfeifer; Christoph Eller; Petra Dem; Frank Schwab
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.